Reviewer #2 (Public review): Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment
Fields of Study & Subjects
PARP inhibition in cancer therapy
Cancer-related gene regulation
DNA Repair Mechanisms
Publication details
- Publication date
- 3 February 2026